The Hsp90 chaperone controls the biogenesis of L7Ae RNPs through conserved machinery

…, B Rothé, C Pescia, MC Robert, T Kiss… - The Journal of cell …, 2008 - rupress.org
RNA-binding proteins of the L7Ae family are at the heart of many essential ribonucleoproteins
(RNPs), including box C/D and H/ACA small nucleolar RNPs, U4 small nuclear RNP, …

Practices in prescribing protein substitutes for PKU in Europe: no uniformity of approach

…, U Meyer, D Moor, A Pal, M Robert… - Molecular genetics and …, 2015 - Elsevier
Background There appears little consensus concerning protein requirements in phenylketonuria
(PKU). Methods A questionnaire completed by 63 European and Turkish IMD centres …

Galectin-1: a small protein with major functions

I Camby, M Le Mercier, F Lefranc, R Kiss - Glycobiology, 2006 - academic.oup.com
Galectins are a family of carbohydrate-binding proteins with an affinity for β-galactosides.
Galectin-1 (Gal-1) is differentially expressed by various normal and pathological tissues and …

[HTML][HTML] Can some marine-derived fungal metabolites become actual anticancer agents?

NGM Gomes, F Lefranc, A Kijjoa, R Kiss - Marine Drugs, 2015 - mdpi.com
Marine fungi are known to produce structurally unique secondary metabolites, and more than
1000 marine fungal-derived metabolites have already been reported. Despite the absence …

Cell culture processes for monoclonal antibody production

F Li, N Vijayasankaran, A Shen, R Kiss, A Amanullah - MAbs, 2010 - Taylor & Francis
Animal cell culture technology has advanced significantly over the last few decades and is
now generally considered a reliable, robust and relatively mature technology. A range of …

3-Aryl-2-quinolone derivatives: synthesis and characterization of in vitro and in vivo antitumor effects with emphasis on a new therapeutical target connected with cell …

…, A Frydman, G Guillaumet, R Kiss - Journal of medicinal …, 2002 - ACS Publications
Among 25 3-aryl-2-quinolone derivatives synthesized, the antitumor activity of some of them
was characterized both in vitro and in vivo. In this series, no compound appeared to be …

[HTML][HTML] Targeting of eEF1A with Amaryllidaceae isocarbostyrils as a strategy to combat melanomas

…, J Hutton, JP Becker, B Lallemand, F Robert… - The FASEB …, 2010 - ncbi.nlm.nih.gov
Melanomas display poor response rates to adjuvant therapies because of their intrinsic
resistance to proapoptotic stimuli. This study indicates that such resistance can be overcome, at …

[HTML][HTML] The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial

…, C Ma, J Comin-Colet, M Fu, SP Janssens, RG Kiss… - Nature medicine, 2022 - nature.com
The sodium–glucose cotransporter 2 inhibitor empagliflozin reduces the risk of cardiovascular
death or heart failure hospitalization in patients with chronic heart failure, but whether …

[HTML][HTML] Long-term use of ticagrelor in patients with prior myocardial infarction

…, S Goto, J Spinar, JC Nicolau, RG Kiss… - … England Journal of …, 2015 - Mass Medical Soc
Background The potential benefit of dual antiplatelet therapy beyond 1 year after a myocardial
infarction has not been established. We investigated the efficacy and safety of ticagrelor, a …

Structure−Activity Relationship Analysis of Novel Derivatives of Narciclasine (an Amaryllidaceae Isocarbostyril Derivative) as Potential Anticancer Agents

…, S Sauvage, M El Yazidi, M Dehoux… - Journal of medicinal …, 2009 - ACS Publications
Narciclasine (1) is a plant growth regulator that has been previously demonstrated to be
proapoptotic to cancer cells at high concentrations (≥1 μM). Data generated in the present …